Copyright
©2007 Baishideng Publishing Group Co.
World J Gastroenterol. May 28, 2007; 13(20): 2798-2802
Published online May 28, 2007. doi: 10.3748/wjg.v13.i20.2798
Published online May 28, 2007. doi: 10.3748/wjg.v13.i20.2798
Table 2 ALT level before and after treatment in each group mean ± SD
Group | n | ALT (U/ L) | ||
Beforeinjection | One week after injection | Three weeks after injection | ||
A (Control) | 12 | 43.56 ± 7.24 | 45.33 ± 8.29 | 75.33 ± 12.51 |
B (Nano HAP) | 11 | 39.29 ± 6.52 | 42.73 ± 10.05d | 59.55 ± 15.40ad |
C (Nano HAP) | 12 | 40.38 ± 6.88 | 43.75 ± 6.30d | 62.00 ± 14.49ad |
D (5-FU) | 11 | 42.70 ± 7.08 | 74.64 ± 15.55b | 99.73 ± 14.70b |
E (5-FU + HAP) | 12 | 42.86 ± 6.79 | 59.67 ± 12.66bc | 86.42 ± 11.54ac |
- Citation: Hu J, Liu ZS, Tang SL, He YM. Effect of hydroxyapatite nanoparticles on the growth and p53/c-Myc protein expression of implanted hepatic VX2 tumor in rabbits by intravenous injection. World J Gastroenterol 2007; 13(20): 2798-2802
- URL: https://www.wjgnet.com/1007-9327/full/v13/i20/2798.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i20.2798